Madrigal Pharmaceuticals, Inc. announced that Dr. Dominic F. Labriola has joined Madrigal as Senior Vice President and Chief Data and Analytics Officer. Dr. Labriola spent more than 20 years at Bristol Myers Squibb as Head of Global Biometric Sciences where he was responsible for the team overseeing the company's NASH program among many other programs. Prior to joining Bristol Myers Squibb, he held positions of increasing responsibility at DuPont Pharmaceutical Company, managing biostatisticians and programmers for multiple therapeutic areas.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
192.9 USD | -0.77% | -8.52% | -16.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.16% | 4.08B | |
-1.81% | 103B | |
+0.46% | 95.71B | |
+1.69% | 22.02B | |
-17.19% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.94% | 15.52B | |
+3.80% | 13.86B | |
+35.84% | 12.04B |
- Stock Market
- Equities
- MDGL Stock
- News Madrigal Pharmaceuticals, Inc.
- Madrigal Pharmaceuticals, Inc Appoints Dominic F. Labriola as Chief Data and Analytics Officer